<DOC>
	<DOCNO>NCT00004466</DOCNO>
	<brief_summary>OBJECTIVES : I . Determine effect atorvastatin plasma level lipid , Lp ( ) , apoproteins treat hyperlipidemia child nephrotic syndrome proteinuria hyperlipidemia persist appropriate measure treat primary disease exhaust . II . Determine safety tolerability atorvastatin patient . III . Provide preliminary data future investigation potential effect lower cholesterol level may rate progression renal insufficiency patient .</brief_summary>
	<brief_title>Pilot Study Atorvastatin Children With Chronic Hyperlipidemia Secondary Nephrotic Syndrome</brief_title>
	<detailed_description>PROTOCOL OUTLINE : This randomize , double blind , placebo control , multicenter study . After 3 month low cholesterol diet , patient randomize receive atorvastatin tablet daily ( arm I ) placebo tablet daily ( arm II ) 3 month . Arm I patient receive increase dos atorvastatin every 4 week individual maximum tolerated dos ( MTDs ) determine . After 3 month treatment , patient give atorvastatin 6-9 month open label extend evaluation . Arm I patient receive atorvastatin additional 6 month arm II patient receive atorvastatin 9 month increase dos atorvastatin every 4 week first 3 month MTDs determine . Patients follow every 6-8 week one year .</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Hyperlipidemias</mesh_term>
	<mesh_term>Nephrotic Syndrome</mesh_term>
	<mesh_term>Nephrosis</mesh_term>
	<mesh_term>Atorvastatin Calcium</mesh_term>
	<criteria>PROTOCOL ENTRY CRITERIA : Disease Characteristics Chronic hyperlipidemia treatmentresistant nephrotic syndrome ; Must receive least 2 month therapy steroid daily alternate basis Primary nephropathy describe minimal change nephrotic syndrome , mesangioproliferative glomerulonephritis , IgM neuropathy , focal segmental glomerulosclerosis Glomerular filtration rate least 30 mL/min LDL cholesterol least 160 mg/dL Prior/Concurrent Therapy No concurrent medication affect interact lipid atorvastatin , exception angiotensin convert enzyme inhibitor discretion refer physician , include : lipidlowering medication , beta blocker , thiazide , fish oil , cyclosporine , Cytoxan , azathioprine , chlorambucil , erythromycin Concurrent prednisone corticosteroid allow continual basis dose great 1 mg/kg every day ( maximum dose , great 40 mg every day ) ; Concurrent acute course steroids great 1 week unrelated condition ( e.g. , asthma ) also allow Patient Characteristics Hepatic : ALT AST less 2 time normal Renal : See Disease Characteristics ; Creatine phosphokinase less 3 time normal Other : No history familial hypercholesterolemia ; No systemic disease systemic lupus , SchoenleinHenoch purpura , Hodgkin 's disease , polyarteritis nodosum , sickle cell disease , HIV ; Not pregnant ; Effective contraception require adolescent patient</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>June 2000</verification_date>
	<keyword>cardiovascular respiratory disease</keyword>
	<keyword>hyperlipidemia</keyword>
	<keyword>nephrotic syndrome</keyword>
	<keyword>rare disease</keyword>
	<keyword>renal genitourinary disorder</keyword>
</DOC>